Jun 25 |
ESLOY vs. PODD: Which Stock Is the Better Value Option?
|
Jun 24 |
Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks
|
Jun 24 |
Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes
|
Jun 24 |
Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes
|
Jun 24 |
Insulet plans label expansion for Omnipod in type 2 diabetes
|
Jun 21 |
Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes
|
Jun 21 |
Insulet (PODD) Faces Increasing Competition
|
Jun 21 |
Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System
|
Jun 20 |
Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands
|
Jun 20 |
Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates
|